Show simple item record

Reduced circulating angiogenic t-cell frequency can predict subclinical vascular stiffness during the earliest stage of rheumatoid arthritis

dc.contributor.authorRodríguez Carrio, Javier 
dc.contributor.authorAlperi López, M.
dc.contributor.authorLópez, P.
dc.contributor.authorPérez Álvarez, A. I.
dc.contributor.authorSuárez Díaz, Ana María 
dc.date.accessioned2023-04-25T10:11:50Z
dc.date.available2023-04-25T10:11:50Z
dc.date.issued2022
dc.identifier.citationAtherosclerosis, 355, p. e106 (2022); doi:10.1016/j.atherosclerosis.2022.06.298
dc.identifier.issn0021-9150
dc.identifier.issn1879-1484
dc.identifier.urihttp://hdl.handle.net/10651/67386
dc.descriptionResumen de congreso n.º EP068
dc.format.extente106
dc.language.isoeng
dc.relation.ispartofAtherosclerosis
dc.rights© 2022 Published by Elsevier Inc.
dc.sourceWOS:000853696400288
dc.titleReduced circulating angiogenic t-cell frequency can predict subclinical vascular stiffness during the earliest stage of rheumatoid arthritis
dc.typeconference outputspa
dc.identifier.doi10.1016/j.atherosclerosis.2022.06.298
dc.relation.publisherversionhttps://doi.org/10.1016/j.atherosclerosis.2022.06.298


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record